Read + Share
Amedeo Smart
Independent Medical Education
Ko M, Lee JY, Shin YS, Jeon S, et al. Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model. J Med Virol 2023;95:e28863.PMID: 37310127
Email
LinkedIn
Facebook
Twitter
Privacy Policy